Steven J Pascoe
Overview
Explore the profile of Steven J Pascoe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee L, Pedersen S, Pascoe S, Szefler S, Lenney W
Pediatr Allergy Immunol
. 2020 Sep;
32(2):377-381.
PMID: 32966707
No abstract available.
2.
Lipson D, Crim C, Criner G, Day N, Dransfield M, Halpin D, et al.
Am J Respir Crit Care Med
. 2020 Mar;
201(12):1508-1516.
PMID: 32162970
The IMPACT (Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment) trial demonstrated a significant reduction in all-cause mortality (ACM) risk with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus UMEC/VI in patients with...
3.
Patel M, McKie E, Steiner M, Pascoe S, Polkey M
BMJ Open Respir Res
. 2019 Sep;
6(1):e000454.
PMID: 31548896
Hypoxia is common in many chronic lung diseases. Beyond pulmonary considerations, delivery of oxygen (O) to the tissues and subsequent O utilisation is also determined by other factors including red...
4.
Pascoe S, Papi A, Midwinter D, Lettis S, Barnes N
Respir Res
. 2019 Aug;
20(1):195.
PMID: 31443653
Background: Patients with chronic obstructive pulmonary disease (COPD) have excess risk of developing pneumonia; however, no definitive biomarkers of risk have been established. We hypothesized that blood neutrophils would help...
5.
Nelsen L, Lee L, Wu W, Lin X, Murray L, Pascoe S, et al.
Respir Res
. 2019 Jun;
20(1):107.
PMID: 31151458
Background: The Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS:COPD) is a patient-reported diary that assesses respiratory symptoms in stable COPD. Methods: This post hoc analysis of a randomized,...
6.
7.
Lipson D, Barnhart F, Brealey N, Brooks J, Criner G, Day N, et al.
N Engl J Med
. 2018 Apr;
378(18):1671-1680.
PMID: 29668352
Background: The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β-agonist (LABA), as compared with dual...
8.
Pascoe S, Wu W, Collison K, Nelsen L, Wurst K, Lee L
Int J Chron Obstruct Pulmon Dis
. 2018 Mar;
13:889-902.
PMID: 29559773
Background: There is no consensus on how to define patients with symptoms of asthma and chronic obstructive pulmonary disease (COPD). A diagnosis of asthma-COPD overlap (ACO) syndrome has been proposed,...
9.
Lipson D, Barnacle H, Birk R, Brealey N, Locantore N, Lomas D, et al.
Am J Respir Crit Care Med
. 2017 Dec;
197(9):1230-1231.
PMID: 29241016
No abstract available.
10.
Cooper C, Brusselle G, Pascoe S, Pavord I
Am J Respir Crit Care Med
. 2017 Nov;
197(7):967-968.
PMID: 29140724
No abstract available.